Suppr超能文献

中国红茶提取物对边缘性高胆固醇血症患者的抗高胆固醇血症作用。

Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia.

作者信息

Fujita Hiroyuki, Yamagami Tomohide

机构信息

Research and Development Department, Nippon Supplement, Inc, Osaka 530-0013, Japan.

出版信息

Nutr Res. 2008 Jul;28(7):450-6. doi: 10.1016/j.nutres.2008.04.005.

Abstract

A water-soluble extract of a traditional Chinese black tea (Pu-Ehr) has been shown to precipitate mixed bile salt micelles in foods. In addition, long-term ingestion of this black tea extract (BTE) significantly reduces blood cholesterol levels in rats. We investigated the effects of BTE tablets (a formula designed to enhance compliance) as a dietary supplement in a 3-month double-blind randomized group comparison study in borderline hypercholesterolemic human subjects (n = 47). All subjects ingested BTE tablets (333 mg) or placebo 3 times daily before meals for 3 months. In the BTE-treated group, the initial mean blood total (6.14 +/- 0.14 mol/L) and low-density lipoprotein (LDL) cholesterol (4.32 +/- 0.14 mol/L) levels decreased with time and were significantly (P < .01) lower (total cholesterol, 5.62 +/- 0.11; LDL cholesterol, 3.81 +/- 0.13 mol/L) after 3 months of ingestion. Furthermore, the mean body weights (P < .05) and triacylglycerol levels (P < .01) were also significantly reduced after 3 months of BTE intake compared with the baseline levels. Significant improvements in the mean LDL cholesterol, body weight, and triacylglycerol values were not accompanied with undesirable changes in other biochemical parameters measured in the subjects. None of the subjects complained of any adverse effects (eg, abdominal distension). The results indicate that BTE intake elicited a significant antihypercholesterolemic effect and might be useful for improving blood cholesterol levels in subjects at risk for heart disease or obesity.

摘要

一种中国传统红茶(普洱茶)的水溶性提取物已被证明能使食物中的混合胆盐微胶粒沉淀。此外,长期摄入这种红茶提取物(BTE)能显著降低大鼠的血液胆固醇水平。我们在一项为期3个月的双盲随机分组对照研究中,对47名边缘性高胆固醇血症患者,研究了作为膳食补充剂的BTE片(一种旨在提高依从性的配方)的效果。所有受试者每天3次在饭前服用BTE片(333毫克)或安慰剂,持续3个月。在BTE治疗组中,最初的平均血液总胆固醇(6.14±0.14毫摩尔/升)和低密度脂蛋白(LDL)胆固醇(4.32±0.14毫摩尔/升)水平随时间下降,在摄入3个月后显著降低(P<.01)(总胆固醇,5.62±0.11;LDL胆固醇,3.81±0.13毫摩尔/升)。此外,与基线水平相比,摄入BTE 3个月后,平均体重(P<.05)和三酰甘油水平(P<.01)也显著降低。平均LDL胆固醇、体重和三酰甘油值的显著改善并未伴随受试者其他生化参数的不良变化。没有受试者抱怨任何不良反应(如腹胀)。结果表明,摄入BTE具有显著的抗高胆固醇血症作用,可能有助于改善有心脏病或肥胖风险的受试者的血液胆固醇水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验